These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37399948)

  • 1. Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma.
    Coccè V; Bonelli M; La Monica S; Alfieri R; Doneda L; Martegani E; Alessandri G; Lagrasta CA; Giannì A; Sordi V; Petrella F; Roncoroni L; Paino F; Pessina A
    Biochem Pharmacol; 2023 Aug; 214():115678. PubMed ID: 37399948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice.
    La Monica S; Coccé V; Bonelli M; Alessandri G; Alfieri R; Lagrasta CA; Frati C; Flammini L; Gianni A; Petrella F; Paino F; Pessina A
    Curr Cancer Drug Targets; 2023; 23(8):663-668. PubMed ID: 36722476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells.
    Coccè V; La Monica S; Bonelli M; Alessandri G; Alfieri R; Lagrasta CA; Madeddu D; Frati C; Flammini L; Lisini D; Marcianti A; Parati E; Paino F; Giannì A; Farronato G; Falco A; Spaggiari L; Petrella F; Pessina A
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
    Bonomi A; Steimberg N; Benetti A; Berenzi A; Alessandri G; Pascucci L; Boniotti J; Coccè V; Sordi V; Pessina A; Mazzoleni G
    Hematol Oncol; 2017 Dec; 35(4):693-702. PubMed ID: 27283119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma.
    Sage EK; Kolluri KK; McNulty K; Lourenco Sda S; Kalber TL; Ordidge KL; Davies D; Gary Lee YC; Giangreco A; Janes SM
    Thorax; 2014 Jul; 69(7):638-47. PubMed ID: 24567297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells mediated delivery of photoactive nanoparticles inhibits osteosarcoma growth in vitro and in a murine in vivo ectopic model.
    Lenna S; Bellotti C; Duchi S; Martella E; Columbaro M; Dozza B; Ballestri M; Guerrini A; Sotgiu G; Frisoni T; Cevolani L; Varchi G; Ferrari M; Donati DM; Lucarelli E
    J Exp Clin Cancer Res; 2020 Feb; 39(1):40. PubMed ID: 32087737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.
    Cova E; Pandolfi L; Colombo M; Frangipane V; Inghilleri S; Morosini M; Mrakic-Sposta S; Moretti S; Monti M; Pignochino Y; Benvenuti S; Prosperi D; Stella G; Morbini P; Meloni F
    Int J Nanomedicine; 2019; 14():773-785. PubMed ID: 30774332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines.
    Cortes-Dericks L; Froment L; Kocher G; Schmid RA
    Stem Cell Res Ther; 2016 Feb; 7():25. PubMed ID: 26861734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded expansile nanoparticles in a multimodal treatment model of malignant mesothelioma.
    Schulz MD; Zubris KA; Wade JE; Padera RF; Xu X; Grinstaff MW; Colson YL
    Ann Thorac Surg; 2011 Dec; 92(6):2007-13; discussion 2013-4. PubMed ID: 21963198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
    Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
    Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
    Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
    Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
    Lei H; Hofferberth SC; Liu R; Colby A; Tevis KM; Catalano P; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1417-24; discussion 1424-25.e1. PubMed ID: 25841659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells.
    Bonomi A; Sordi V; Dugnani E; Ceserani V; Dossena M; Coccè V; Cavicchini L; Ciusani E; Bondiolotti G; Piovani G; Pascucci L; Sisto F; Alessandri G; Piemonti L; Parati E; Pessina A
    Cytotherapy; 2015 Dec; 17(12):1687-95. PubMed ID: 26481416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Pleural Mesothelioma: State of the art and advanced cell therapy.
    Facchetti G; Petrella F; Spaggiari L; Rimoldi I
    Eur J Med Chem; 2017 Dec; 142():266-270. PubMed ID: 28800871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response.
    Zhang J; Khanna S; Jiang Q; Alewine C; Miettinen M; Pastan I; Hassan R
    Clin Cancer Res; 2017 Mar; 23(6):1564-1574. PubMed ID: 27635089
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model.
    Sonvico F; Barbieri S; Colombo P; Barocelli E; Mucchino C; Cantoni AM; Petronini PG; Rusca M; Carbognani P; Ampollini L
    Eur J Pharm Sci; 2018 Oct; 123():89-97. PubMed ID: 30030099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.